Overview

To Evaluate The Efficacy And Safety Of Sunpharma1505 Compared With Reference1505 In Subjects With Active Rheumatoid Arthritis

Status:
Terminated
Trial end date:
2018-06-01
Target enrollment:
Participant gender:
Summary
This study is designated to evaluate the safety and efficacy of Sunpharma1505 in subjects with active rheumatoid arthritis who are experiencing a flare/exacerbation.
Phase:
Phase 3
Details
Lead Sponsor:
Sun Pharma Global FZE